Officer and Director Steven Williamson Files Intent to Sell Additional Shares After Recent Dispositions
LUNG sits 46% above its 52-week low of $1.31 on light trading volume (0.1× avg).
Summary
Steven Williamson, an Officer and Director of Pulmonx Corp, filed a Form 144 indicating intent to sell 48,892 shares valued at approximately $95,339, following recent sales of 46,974 shares.
Key Events · Ownership and Investor Activity · LUNG
-
Officer Files Intent to Sell
Steven Williamson, an Officer and Director, filed a Form 144 to sell 48,892 common shares.
-
Value of Proposed Sale
The proposed sale is valued at approximately $95,339.40 based on the current stock price.
-
Recent Insider Selling Activity
This filing follows recent sales by Mr. Williamson of 46,974 shares, totaling $93,112.29, within the past three months.
Analysis · LUNG · Industrial Applications And Services
This Form 144 filing indicates an ongoing disposition of shares by a key insider. Steven Williamson, an Officer and Director, intends to sell additional shares, following recent sales within the past three months. While the proposed sale of approximately $95,339 is not massive in absolute terms, it represents a notable transaction for an individual at this company size. The pattern of continued selling by an Officer and Director could be interpreted negatively by investors, signaling a potential lack of confidence or a desire to reduce exposure.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LUNG was trading at $1.91 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $78.8M. The 52-week trading range was $1.31 to $9.37. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.